Multiple Assemblies exist for SMTL entry 5tq7
Design and Synthesis of a pan-JAK Kinase Inhibitor Clinical Candidate (PF-06263276) Suitable for Inhaled and Topical Delivery for the Treatment of Inflammatory Diseases of the Lungs and Skin; X-RAY DIFFRACTION 2.10 Å

	SMTL ID 5tq7.1 Ligands {(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}[(3R)-3-(phenylsulfonyl)pyrrolidin-1-yl]methanone Polypeptides Tyrosine-protein kinase JAK2 Oligo-state monomer
	SMTL ID 5tq7.2 Ligands {(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}[(3R)-3-(phenylsulfonyl)pyrrolidin-1-yl]methanone Polypeptides Tyrosine-protein kinase JAK2 Oligo-state monomer